DE69800970D1 - Pyridinderivate und sie enthaltende pharmazeutische zubereitungen - Google Patents
Pyridinderivate und sie enthaltende pharmazeutische zubereitungenInfo
- Publication number
- DE69800970D1 DE69800970D1 DE69800970T DE69800970T DE69800970D1 DE 69800970 D1 DE69800970 D1 DE 69800970D1 DE 69800970 T DE69800970 T DE 69800970T DE 69800970 T DE69800970 T DE 69800970T DE 69800970 D1 DE69800970 D1 DE 69800970D1
- Authority
- DE
- Germany
- Prior art keywords
- pharmaceutical preparations
- preparations containing
- pyride
- derivatives
- pyride derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9701194A SE9701194D0 (sv) | 1997-04-01 | 1997-04-01 | Novel compounds |
| SE9702200A SE9702200D0 (sv) | 1997-06-09 | 1997-06-09 | Novel compounds |
| SE9704402A SE9704402D0 (sv) | 1997-11-28 | 1997-11-28 | Novel compounds |
| PCT/SE1998/000575 WO1998043971A1 (en) | 1997-04-01 | 1998-03-27 | Novel pyridine derivatives and pharmaceutical compositions containing them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69800970D1 true DE69800970D1 (de) | 2001-07-26 |
| DE69800970T2 DE69800970T2 (de) | 2002-04-04 |
Family
ID=27355867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69800970T Expired - Fee Related DE69800970T2 (de) | 1997-04-01 | 1998-03-27 | Pyridinderivate und sie enthaltende pharmazeutische zubereitungen |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6143751A (de) |
| EP (1) | EP0984961B1 (de) |
| JP (1) | JP2001517228A (de) |
| KR (1) | KR20010005840A (de) |
| CN (1) | CN1258296A (de) |
| AR (1) | AR012216A1 (de) |
| AT (1) | ATE202351T1 (de) |
| AU (1) | AU6861198A (de) |
| BR (1) | BR9808447A (de) |
| CA (1) | CA2284597A1 (de) |
| DE (1) | DE69800970T2 (de) |
| DK (1) | DK0984961T3 (de) |
| EE (1) | EE9900435A (de) |
| ES (1) | ES2159943T3 (de) |
| GR (1) | GR3036638T3 (de) |
| ID (1) | ID23163A (de) |
| IL (1) | IL131854A0 (de) |
| NO (1) | NO994764D0 (de) |
| PL (1) | PL335884A1 (de) |
| PT (1) | PT984961E (de) |
| SK (1) | SK133399A3 (de) |
| TR (1) | TR199902433T2 (de) |
| WO (1) | WO1998043971A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002534414A (ja) * | 1999-01-08 | 2002-10-15 | バーテックス ファーマシューティカルズ インコーポレイテッド | 医薬の製造に有用な中間体の形成方法 |
| CA2314458A1 (en) | 1999-08-02 | 2001-02-02 | Kazumi Okuro | Process for production of 3-(3-pyridyl)-1-propanol derivatives |
| US6376524B1 (en) | 2000-06-21 | 2002-04-23 | Sunesis Pharmaceuticals, Inc. | Triphenyl compounds as interleukin-4 antagonists |
| JO3598B1 (ar) * | 2006-10-10 | 2020-07-05 | Infinity Discovery Inc | الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني |
| EP2531511A1 (de) * | 2010-02-03 | 2012-12-12 | Infinity Pharmaceuticals, Inc. | Fettsäureamidhydrolase-hemmer |
| WO2013097052A1 (en) | 2011-12-30 | 2013-07-04 | Abbott Laboratories | Bromodomain inhibitors |
| WO2013185284A1 (en) | 2012-06-12 | 2013-12-19 | Abbott Laboratories | Pyridinone and pyridazinone derivatives |
| CN109071534B (zh) | 2016-04-15 | 2021-11-23 | 艾伯维公司 | 布罗莫结构域抑制剂 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0267439A3 (de) * | 1986-10-14 | 1988-08-31 | G.D. Searle & Co. | Alpha-(phenylalkyl)pyridinalkanol-Derivate |
| AU7975887A (en) * | 1986-10-16 | 1988-04-21 | G.D. Searle & Co. | Alpha-((phenylmethoxy)methyl)pyridine alkanols |
| SK73998A3 (en) * | 1995-12-06 | 1999-02-11 | Astra Pharma Prod | Compounds |
-
1998
- 1998-03-27 TR TR1999/02433T patent/TR199902433T2/xx unknown
- 1998-03-27 KR KR1019997008914A patent/KR20010005840A/ko not_active Application Discontinuation
- 1998-03-27 DK DK98914202T patent/DK0984961T3/da active
- 1998-03-27 JP JP54155998A patent/JP2001517228A/ja active Pending
- 1998-03-27 AU AU68611/98A patent/AU6861198A/en not_active Abandoned
- 1998-03-27 EP EP98914202A patent/EP0984961B1/de not_active Expired - Lifetime
- 1998-03-27 DE DE69800970T patent/DE69800970T2/de not_active Expired - Fee Related
- 1998-03-27 PT PT98914202T patent/PT984961E/pt unknown
- 1998-03-27 IL IL13185498A patent/IL131854A0/xx unknown
- 1998-03-27 EE EEP199900435A patent/EE9900435A/xx unknown
- 1998-03-27 ID IDW991125D patent/ID23163A/id unknown
- 1998-03-27 US US09/068,521 patent/US6143751A/en not_active Expired - Fee Related
- 1998-03-27 CN CN98805505A patent/CN1258296A/zh active Pending
- 1998-03-27 ES ES98914202T patent/ES2159943T3/es not_active Expired - Lifetime
- 1998-03-27 PL PL98335884A patent/PL335884A1/xx unknown
- 1998-03-27 SK SK1333-99A patent/SK133399A3/sk unknown
- 1998-03-27 CA CA002284597A patent/CA2284597A1/en not_active Abandoned
- 1998-03-27 AT AT98914202T patent/ATE202351T1/de not_active IP Right Cessation
- 1998-03-27 WO PCT/SE1998/000575 patent/WO1998043971A1/en not_active Application Discontinuation
- 1998-03-27 BR BR9808447-0A patent/BR9808447A/pt not_active IP Right Cessation
- 1998-03-31 AR ARP980101459A patent/AR012216A1/es unknown
-
1999
- 1999-09-30 NO NO994764A patent/NO994764D0/no not_active Application Discontinuation
-
2001
- 2001-09-18 GR GR20010401496T patent/GR3036638T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2159943T3 (es) | 2001-10-16 |
| CN1258296A (zh) | 2000-06-28 |
| DK0984961T3 (da) | 2001-09-17 |
| US6143751A (en) | 2000-11-07 |
| AU6861198A (en) | 1998-10-22 |
| SK133399A3 (en) | 2000-05-16 |
| BR9808447A (pt) | 2000-05-23 |
| ID23163A (id) | 2000-03-23 |
| GR3036638T3 (en) | 2001-12-31 |
| CA2284597A1 (en) | 1998-10-08 |
| PT984961E (pt) | 2001-11-30 |
| EP0984961A1 (de) | 2000-03-15 |
| KR20010005840A (ko) | 2001-01-15 |
| EP0984961B1 (de) | 2001-06-20 |
| AR012216A1 (es) | 2000-09-27 |
| TR199902433T2 (xx) | 2000-04-21 |
| DE69800970T2 (de) | 2002-04-04 |
| WO1998043971A1 (en) | 1998-10-08 |
| IL131854A0 (en) | 2001-03-19 |
| NO994764L (no) | 1999-09-30 |
| JP2001517228A (ja) | 2001-10-02 |
| PL335884A1 (en) | 2000-05-22 |
| EE9900435A (et) | 2000-04-17 |
| ATE202351T1 (de) | 2001-07-15 |
| NO994764D0 (no) | 1999-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69814091D1 (de) | Voriconazol-enthaltende pharmazeutische zubereitungen | |
| DE69618587D1 (de) | Chinazoline und pharmazeutische zusammensetzungen | |
| FI953479A0 (fi) | 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö | |
| ATE288419T1 (de) | Alpha-aryl-n-alkylnitrone sowie diese enthaltende pharmazeutische zubereitungen | |
| DE59813619D1 (de) | Ascorbinsäurederivate enthaltende kosmetische und pharmazeutische Zubereitungen | |
| KR950703566A (ko) | 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof] | |
| ATE304351T1 (de) | Arzneizubereitungen enthaltend kannabinoide | |
| DE59808804D1 (de) | Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate | |
| NO20002359L (no) | Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene | |
| NO993868D0 (no) | 3-piperidyl-4-oksokinazolin-derivater og medisinske preparater som inneholder slike | |
| ATE234078T1 (de) | Pharmazeutische omeprazol-formulierung | |
| ATE243516T1 (de) | Amoxicillin und clavulanat enthaltende arzneizubereitungen | |
| DE69419601D1 (de) | Aminderivate und sie enthaltende dermatologische zubereitungen | |
| DE59704397D1 (de) | Kosmetische und/oder pharmazeutische zubereitungen | |
| DE69732649D1 (de) | Heteroarylsulfonamidderivate und diese enthaltende pharmazeutische zubereitungen | |
| ATE240315T1 (de) | Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate | |
| DE69625326D1 (de) | Anthracyclinderivate und sie enthaldende medizinische zubereitungen | |
| BR9602915A (pt) | Medicamentos uso e formulação farmacêutica | |
| DE59607535D1 (de) | Kosmetische und/oder pharmazeutische zubereitungen | |
| DE68917499D1 (de) | Catechol-Derivate und sie enthaltende pharmazeutische Präparate. | |
| DE69705324D1 (de) | N-hydroxyharnstoffderivate und sie enthaltende medizinische zubereitungen | |
| ATE383868T1 (de) | Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka | |
| ATE449786T1 (de) | Imidazolidinderivate, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate | |
| DE69024843D1 (de) | Rhodanin-Derivate und pharmazeutische Zusammensetzungen | |
| DE59505714D1 (de) | Kosmetische und/oder pharmazeutische zubereitungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |